In Nanjing, we formally signed an investment contract as a major project of the 2021 China (Nanjing) Golden Autumn Economic and Trade Fair.

In Beijing, we were successfully selected as the "REAL 100 Innovators" of Jiemian News.

A double blessing has descended upon the house!

The leader of 3D printing pharmaceuticals signed an investment contract on Golden Autumn Economic and Trade Fair

On October 13th, at the signing ceremony for 62 major projects of the 2021 China (Nanjing) Golden Autumn Economic and Trade Fair, Triastek formally signed an investment contract with the Jiangning District Government.

Triastek will locate its global R&D headquarters and the world's first 3D printing smart pharmaceutical factory in Jiangning, Nanjing. As a global leader in the field of 3D printing pharmaceuticals, Triastek will give full play to its advantages in the entire industry chain of 3D printing pharmaceuticals, and continue to promote the global demonstration effect and industrialization innovation breakthroughs of 3D printing pharmaceuticals.

Dr. Senping Cheng, founder and CEO of Triastek, said, “The development of emerging technologies requires fertile ground. Let us witness the birth of the world's first 3D printing smart pharmaceutical factory in Nanjing.

Triastek was selected into the "REAL 100 Innovators" list

On October 13, Jiemian News released the first "REAL 100 Innovators" list. With the innovation and contribution in the field of global 3D printing drugs, Triastek was successfully selected into the new health track list.

Dr. Senping Cheng said, “With six years of innovation and entrepreneurship, Triastek is ready for a long journey. We will try best to make our technology and products spread far and wide across the globe.”